Overview
Intuitive Surgical, Inc., based in the United States, is a prominent pioneer in the field of robotic-assisted, minimally invasive surgery. Central to its portfolio is the renowned da Vinci Surgical System, which enhances surgical precision and dexterity while minimizing patient recovery times. Beyond its flagship technology, the company invests heavily in research and development to refine its existing systems and innovate new solutions that address complex surgical challenges. Key projects focus on expanding the applicability of robotics across a broader range of surgical procedures and enhancing the integration of advanced imaging and data analytics to improve surgical outcomes. These efforts underscore Intuitive Surgical's commitment to advancing the field of surgical robotics and expanding its market presence globally.
Basic Stats
The Factor Analysis chart (below right) shows a view of Intuitive Surgical, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 353.13 MM |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | 0.00 |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 0.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Intuitive Surgical, Inc. is MX$11,263.58. The forecasts range from a low of MX$8,357.07 to a high of MX$13,525.70. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Intuitive Surgical, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-11-26 | BTIG | Buy | Buy | Maintains |
| 2025-04-23 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-04-23 | Truist Securities | Buy | Buy | Maintains |
| 2025-04-23 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-04-23 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2025-04-23 | Baird | Outperform | Outperform | Maintains |
| 2025-07-23 | Truist Securities | Buy | Buy | Maintains |
| 2025-07-23 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2025-07-23 | UBS | Neutral | Neutral | Maintains |
| 2025-07-23 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-23 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-07-23 | BTIG | Buy | Buy | Maintains |
| 2024-07-19 | BTIG | Buy | Buy | Maintains |
| 2024-07-19 | Truist Securities | Buy | Buy | Maintains |
| 2024-07-19 | Stifel | Buy | Buy | Maintains |
| 2024-07-19 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-19 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-07-19 | Baird | Outperform | Outperform | Maintains |
| 2024-07-18 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-16 | Truist Securities | Buy | Buy | Maintains |
| 2024-07-15 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-15 | BTIG | Buy | Buy | Maintains |
| 2024-07-10 | Citigroup | Buy | Buy | Maintains |
| 2024-07-09 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-07-02 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-05-30 | Goldman Sachs | Buy | Initiate | |
| 2024-04-19 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-04-19 | BTIG | Buy | Buy | Maintains |
| 2024-04-19 | Jefferies | Hold | Hold | Maintains |
| 2024-04-19 | Baird | Outperform | Outperform | Maintains |
| 2024-04-08 | Stifel | Buy | Buy | Maintains |
| 2024-04-03 | Citigroup | Buy | Buy | Maintains |
| 2024-03-15 | Stifel | Buy | Buy | Reiterate |
| 2024-01-25 | Mizuho | Neutral | Neutral | Maintains |
| 2024-01-25 | Barclays | Overweight | Overweight | Maintains |
| 2024-01-25 | Raymond James | Outperform | Outperform | Maintains |
| 2024-01-24 | Truist Securities | Buy | Buy | Maintains |
| 2024-01-24 | Stifel | Buy | Buy | Maintains |
| 2024-01-24 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-24 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-01-19 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-01-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-03 | Raymond James | Outperform | Outperform | Maintains |
| 2023-12-22 | Truist Securities | Buy | Buy | Maintains |
| 2023-12-12 | Truist Securities | Buy | Buy | Maintains |
| 2023-12-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-17 | Stifel | Buy | Buy | Maintains |
| 2023-11-17 | HSBC | Buy | Initiate | |
| 2023-10-23 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-20 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-10-20 | Citigroup | Buy | Buy | Maintains |
| 2023-10-20 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-10-20 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-10-20 | Raymond James | Outperform | Outperform | Maintains |
| 2023-10-16 | Leerink Partners | Outperform | Initiate | |
| 2023-08-17 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-07-24 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-24 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-24 | Raymond James | Outperform | Outperform | Maintains |
| 2023-07-21 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-07-21 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-07-21 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-21 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-07-19 | Truist Securities | Buy | Buy | Maintains |
| 2023-07-19 | Baird | Outperform | Outperform | Initiate |
| 2023-07-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-11 | Citigroup | Buy | Buy | Maintains |
| 2023-06-05 | BTIG | Buy | Buy | Maintains |
| 2023-05-31 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-05-31 | Bernstein | Outperform | Outperform | Maintains |
| 2023-05-18 | Truist Securities | Buy | Buy | Maintains |
| 2023-04-24 | RBC Capital | Outperform | Reiterate | |
| 2023-04-20 | Bernstein | Outperform | Maintains | |
| 2023-04-20 | Barclays | Overweight | Maintains | |
| 2023-04-19 | Evercore ISI Group | In-Line | Maintains | |
| 2023-04-19 | BTIG | Buy | Maintains | |
| 2023-04-19 | Piper Sandler | Overweight | Maintains | |
| 2023-04-19 | Deutsche Bank | Hold | Maintains | |
| 2023-04-19 | Stifel | Buy | Maintains | |
| 2023-04-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-04-19 | RBC Capital | Outperform | Maintains | |
| 2023-04-19 | JP Morgan | Overweight | Maintains | |
| 2023-04-19 | Truist Securities | Buy | Maintains | |
| 2023-04-19 | B of A Securities | Buy | Maintains | |
| 2023-04-19 | Raymond James | Outperform | Maintains | |
| 2023-04-19 | Wells Fargo | Overweight | Maintains | |
| 2023-04-19 | Mizuho | Neutral | Maintains | |
| 2023-04-19 | Citigroup | Buy | Maintains | |
| 2023-04-18 | Mizuho | Neutral | Maintains | |
| 2023-04-17 | BTIG | Buy | Maintains | |
| 2023-04-04 | Evercore ISI Group | In-Line | Maintains | |
| 2023-03-29 | UBS | Neutral | Initiate | |
| 2023-03-23 | William Blair | Outperform | Initiate | |
| 2023-01-26 | Raymond James | Outperform | Maintains | |
| 2023-01-25 | BTIG | Buy | Maintains | |
| 2023-01-25 | Citigroup | Buy | Maintains | |
| 2023-01-25 | Mizuho | Neutral | Maintains | |
| 2023-01-25 | Truist Securities | Buy | Maintains | |
| 2023-01-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-01-25 | Wells Fargo | Overweight | Maintains | |
| 2023-01-24 | Mizuho | Neutral | Maintains | |
| 2023-01-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-12-22 | Argus Research | Buy | Maintains | |
| 2022-12-20 | Truist Securities | Buy | Maintains | |
| 2022-12-12 | Wells Fargo | Overweight | Maintains | |
| 2022-12-05 | BTIG | Buy | Maintains | |
| 2022-11-18 | JP Morgan | Overweight | Maintains | |
| 2022-10-20 | Deutsche Bank | Hold | Maintains | |
| 2022-10-19 | Wells Fargo | Overweight | Maintains | |
| 2022-10-19 | Truist Securities | Buy | Maintains | |
| 2022-10-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-19 | Piper Sandler | Overweight | Maintains | |
| 2022-10-18 | Barclays | Overweight | Initiate | |
| 2022-10-17 | Truist Securities | Buy | Maintains | |
| 2022-10-13 | Mizuho | Neutral | Initiate | |
| 2022-10-12 | Jefferies | Hold | Initiate | |
| 2022-10-11 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-09-09 | Stifel | Buy | Maintains | |
| 2022-08-18 | Piper Sandler | Overweight | Maintains | |
| 2022-07-22 | RBC Capital | Outperform | Maintains | |
| 2022-07-22 | Deutsche Bank | Hold | Maintains | |
| 2022-07-22 | Truist Securities | Buy | Maintains | |
| 2022-07-22 | Citigroup | Buy | Maintains | |
| 2022-07-22 | Piper Sandler | Overweight | Maintains | |
| 2022-07-22 | Raymond James | Outperform | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-18 | BTIG | Buy | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-15 | Raymond James | Outperform | Maintains | |
| 2022-07-13 | Truist Securities | Buy | Maintains | |
| 2022-06-22 | Deutsche Bank | Hold | Maintains | |
| 2022-05-17 | Citigroup | Buy | Maintains | |
| 2022-04-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-04-22 | Wells Fargo | Overweight | Maintains | |
| 2022-04-22 | Raymond James | Outperform | Maintains | |
| 2022-04-22 | Piper Sandler | Overweight | Maintains | |
| 2022-04-13 | Truist Securities | Buy | Initiate | |
| 2022-04-06 | Wolfe Research | Peer Perform | Initiate | |
| 2022-03-25 | RBC Capital | Outperform | Initiate | |
| 2022-02-02 | UBS | Neutral | Buy | Upgrade |
| 2022-01-31 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2022-01-25 | Redburn Partners | Buy | Neutral | Downgrade |
| 2022-01-21 | Piper Sandler | Neutral | Maintains | |
| 2022-01-21 | Deutsche Bank | Hold | Maintains | |
| 2022-01-21 | Raymond James | Outperform | Maintains | |
| 2022-01-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-01-21 | Wells Fargo | Overweight | Maintains | |
| 2022-01-21 | Citigroup | Neutral | Buy | Upgrade |
| 2022-01-10 | BTIG | Neutral | Buy | Upgrade |
| 2022-01-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-20 | Wells Fargo | Overweight | Maintains | |
| 2021-10-05 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-01 | Citigroup | Buy | Neutral | Downgrade |
| 2021-08-26 | SVB Leerink | Market Perform | Maintains | |
| 2021-07-22 | Deutsche Bank | Hold | Maintains | |
| 2021-07-21 | Wells Fargo | Overweight | Maintains | |
| 2021-07-21 | Evercore ISI Group | In-Line | Maintains | |
| 2021-07-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-07-21 | Citigroup | Buy | Maintains | |
| 2021-07-20 | SVB Leerink | Market Perform | Maintains | |
| 2021-07-14 | Stifel | Buy | Maintains | |
| 2021-06-07 | Wells Fargo | Overweight | Maintains | |
| 2021-06-01 | Evercore ISI Group | Underperform | In-Line | Upgrade |
| 2021-05-24 | Argus Research | Buy | Maintains | |
| 2021-04-21 | Piper Sandler | Neutral | Maintains | |
| 2021-04-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-04-21 | Citigroup | Buy | Maintains | |
| 2021-04-21 | Deutsche Bank | Hold | Maintains | |
| 2021-04-21 | Oppenheimer | Underperform | Perform | Upgrade |
| 2021-04-21 | SVB Leerink | Market Perform | Maintains | |
| 2021-04-21 | Baird | Neutral | Outperform | Upgrade |
| 2021-04-01 | Citigroup | Buy | Initiate | |
| 2021-03-31 | Piper Sandler | Neutral | Maintains | |
| 2021-01-22 | Raymond James | Outperform | Maintains | |
| 2020-12-15 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2020-10-16 | SVB Leerink | Market Perform | Maintains | |
| 2020-10-16 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-16 | Wells Fargo | Overweight | Maintains | |
| 2020-10-12 | Raymond James | Outperform | Maintains | |
| 2020-09-28 | Argus Research | Buy | Initiate | |
| 2020-09-11 | Wolfe Research | Outperform | Initiate | |
| 2020-09-08 | B of A Securities | Buy | Neutral | Downgrade |
| 2020-09-02 | Baird | Neutral | Initiate | |
| 2020-08-14 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-22 | Canaccord Genuity | Buy | Maintains | |
| 2020-07-22 | Wells Fargo | Overweight | Maintains | |
| 2020-07-22 | Stifel | Buy | Maintains | |
| 2020-07-22 | UBS | Neutral | Maintains | |
| 2020-07-22 | Morgan Stanley | Overweight | Maintains | |
| 2020-07-22 | Deutsche Bank | Hold | Maintains | |
| 2020-07-22 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-22 | Raymond James | Outperform | Maintains | |
| 2020-07-15 | SVB Leerink | Market Perform | Maintains | |
| 2020-06-18 | JP Morgan | Overweight | Maintains | |
| 2020-06-04 | Wells Fargo | Overweight | Maintains | |
| 2020-04-28 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2020-04-17 | Canaccord Genuity | Buy | Maintains | |
| 2020-04-17 | UBS | Neutral | Maintains | |
| 2020-04-17 | Wells Fargo | Overweight | Maintains | |
| 2020-04-17 | Deutsche Bank | Hold | Maintains | |
| 2020-04-17 | SVB Leerink | Outperform | Market Perform | Downgrade |
| 2020-04-13 | Raymond James | Outperform | Maintains | |
| 2020-04-09 | Evercore ISI Group | In-Line | Underperform | Downgrade |
| 2020-04-02 | Wells Fargo | Overweight | Maintains | |
| 2020-04-01 | Oppenheimer | Perform | Underperform | Downgrade |
| 2020-03-27 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-24 | Stifel | Buy | Maintains | |
| 2020-03-17 | JP Morgan | Overweight | Maintains | |
| 2020-02-13 | Goldman Sachs | Buy | Initiate | |
| 2020-01-27 | Deutsche Bank | Buy | Hold | Downgrade |
| 2020-01-24 | Raymond James | Outperform | Maintains | |
| 2020-01-24 | JP Morgan | Overweight | Maintains | |
| 2020-01-10 | UBS | Neutral | Maintains | |
| 2020-01-10 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2019-12-17 | Morgan Stanley | Overweight | Maintains | |
| 2019-11-29 | First Shanghai | Buy | Initiate | |
| 2019-11-21 | Oppenheimer | Perform | Initiate | |
| 2019-10-18 | UBS | Neutral | Maintains | |
| 2019-07-19 | Canaccord Genuity | Buy | Maintains | |
| 2019-05-14 | Citigroup | Buy | Maintains | |
| 2019-04-23 | Citigroup | Buy | Buy | Maintains |
| 2019-04-22 | Canaccord Genuity | Buy | Buy | Maintains |
| 2019-04-22 | Raymond James | Outperform | Outperform | Maintains |
| 2019-04-02 | Deutsche Bank | Buy | Initiate | |
| 2019-04-01 | Raymond James | Outperform | Outperform | Maintains |
| 2019-01-02 | Citigroup | Buy | Buy | Maintains |
| 2018-11-29 | Citigroup | Buy | Buy | Maintains |
| 2018-11-28 | UBS | Neutral | Initiate | |
| 2018-10-19 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2018-10-19 | Raymond James | Outperform | Outperform | Maintains |
| 2018-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-10 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2018-10-09 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2018-09-12 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-08-02 | Citigroup | Buy | Buy | Maintains |
| 2018-07-20 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-07-20 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-07-17 | Bank of America | Buy | Buy | Maintains |
| 2018-06-27 | Bernstein | Outperform | Initiate | |
| 2018-06-01 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-18 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-18 | Bank of America | Buy | Buy | Maintains |
| 2018-04-18 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-04-18 | Canaccord Genuity | Hold | Hold | Maintains |
| 2018-02-06 | Citigroup | Buy | Buy | Maintains |
| 2018-01-26 | Barclays | Overweight | Overweight | Maintains |
| 2018-01-26 | Canaccord Genuity | Hold | Hold | Maintains |
| 2018-01-26 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-01-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-01-03 | Evercore ISI Group | In-Line | Initiate | |
| 2017-10-23 | Citigroup | Buy | Maintains | |
| 2017-10-20 | Barclays | Overweight | Maintains | |
| 2017-10-20 | Morgan Stanley | Overweight | Maintains | |
| 2017-07-25 | Morgan Stanley | Overweight | Maintains | |
| 2017-06-30 | Cantor Fitzgerald | Neutral | Initiate | |
| 2017-05-16 | Goldman Sachs | Buy | Initiate | |
| 2017-01-04 | Evercore ISI Group | Buy | Hold | Downgrade |
| 2016-10-13 | Wells Fargo | Outperform | Initiate | |
| 2016-08-26 | Raymond James | Outperform | Initiate | |
| 2016-07-20 | Citigroup | Buy | Maintains | |
| 2016-07-20 | Barclays | Overweight | Maintains | |
| 2016-06-02 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2016-04-20 | Bank of America | Buy | Maintains | |
| 2016-04-01 | BTIG Research | Buy | Neutral | Downgrade |
| 2016-01-04 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2015-11-12 | Citigroup | Buy | Initiate | |
| 2015-07-22 | Barclays | Overweight | Maintains | |
| 2015-07-06 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2015-06-25 | Barclays | Overweight | Initiate | |
| 2015-05-12 | PiperJaffray | Neutral | Initiate | |
| 2015-01-05 | Jefferies | Buy | Maintains | |
| 2015-01-02 | Bank of America | Buy | Maintains | |
| 2014-10-22 | Northland Securities | Underperform | Market Perform | Upgrade |
| 2014-10-22 | BTIG Research | Neutral | Buy | Upgrade |
| 2014-10-17 | Leerink Swann | Market Perform | Outperform | Upgrade |
| 2014-10-06 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2014-09-22 | RBC Capital | Sector Perform | Initiate | |
| 2014-07-23 | JP Morgan | Overweight | Maintains | |
| 2014-07-23 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2014-07-23 | Raymond James | Market Perform | Outperform | Upgrade |
| 2014-07-08 | BTIG Research | Neutral | Initiate | |
| 2014-04-29 | Sterne Agee | Underperform | Neutral | Upgrade |
| 2014-04-23 | Canaccord Genuity | Hold | Maintains | |
| 2014-04-23 | Sterne Agee | Underperform | Maintains | |
| 2014-04-23 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2014-04-23 | Leerink Swann | Market Perform | Maintains | |
| 2014-04-23 | JP Morgan | Overweight | Maintains | |
| 2014-04-14 | Leerink Swann | Market Perform | Maintains | |
| 2014-04-09 | Sterne Agee | Underperform | Initiate | |
| 2014-04-08 | Sterne Agee | Underperform | Initiate | |
| 2014-04-02 | JMP Securities | Market Underperform | Market Outperform | Upgrade |
| 2014-04-02 | Bank of America | Buy | Maintains | |
| 2014-04-01 | JP Morgan | Overweight | Maintains | |
| 2014-03-04 | Cantor Fitzgerald | Buy | Hold | Downgrade |
| 2014-01-21 | ISI Group | Strong Buy | Initiate | |
| 2013-12-05 | Jefferies | Buy | Initiate | |
| 2013-11-26 | CRT Capital | Sell | Initiate | |
| 2013-11-25 | CRT Capital | Sell | Initiate | |
| 2013-10-18 | Northland | Market Perform | Underperform | Downgrade |
| 2013-09-03 | First Analysis | Equal-Weight | Underweight | Downgrade |
| 2013-07-19 | Northland Securities | Underperform | Market Perform | Upgrade |
| 2013-07-19 | JMP Securities | Market Perform | Market Underperform | Downgrade |
| 2013-07-09 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2013-07-09 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2013-07-09 | Ameriprise Financial | Buy | Sell | Downgrade |
| 2013-07-09 | JMP Securities | Market Outperform | Market Perform | Downgrade |
| 2013-07-09 | Raymond James | Outperform | Market Perform | Downgrade |
| 2013-06-25 | First Analysis | Equal-Weight | Initiate | |
| 2013-06-18 | Wedbush | Outperform | Initiate | |
| 2013-06-17 | Wedbush | Outperform | Initiate | |
| 2013-03-18 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2013-03-05 | Northland | Underperform | Initiate | |
| 2013-03-01 | Cantor Fitzgerald | Hold | Buy | Upgrade |
| 2013-02-22 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2013-01-23 | Cantor Fitzgerald | Hold | Maintains | |
| 2013-01-18 | Janney Capital | Buy | Initiate | |
| 2013-01-17 | Janney Capital | Buy | Initiate | |
| 2013-01-16 | Goldman Sachs | Neutral | Maintains | |
| 2013-01-14 | Lazard | Neutral | Buy | Upgrade |
| 2012-12-04 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-11-20 | Stifel Nicolaus | Hold | Initiate | |
| 2012-10-31 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2012-10-19 | Bank of America | Neutral | Buy | Upgrade |
| 2012-10-15 | JP Morgan | Neutral | Overweight | Upgrade |
| 2012-08-27 | Goldman Sachs | Neutral | Maintains | |
| 2012-07-25 | Mizuho | Neutral | Buy | Upgrade |
| 2012-05-30 | JP Morgan | Neutral | Maintains | |
| 2012-04-18 | JP Morgan | Neutral | Maintains | |
| 2012-04-18 | Goldman Sachs | Neutral | Maintains | |
| 2012-04-18 | Dougherty | Buy | Maintains | |
| 2012-04-18 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-04-10 | Dougherty | Buy | Initiate | |
| 2024-12-05 | Stifel | Buy | Buy | Maintains |
| 2024-07-23 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-19 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-19 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-07-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-10-01 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-08-28 | BTIG | Buy | Buy | Maintains |
| 2024-12-02 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2024-08-02 | Redburn Atlantic | Neutral | Buy | Upgrade |
| 2024-10-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-12-18 | Truist Securities | Buy | Buy | Maintains |
| 2024-08-22 | Citigroup | Buy | Buy | Maintains |
| 2024-10-18 | BTIG | Buy | Buy | Maintains |
| 2024-10-18 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-10-18 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2024-10-18 | Stifel | Buy | Buy | Maintains |
| 2024-10-18 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-18 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-18 | Baird | Outperform | Outperform | Maintains |
| 2024-10-14 | BTIG | Buy | Buy | Maintains |
| 2024-10-14 | Raymond James | Outperform | Outperform | Maintains |
| 2024-10-14 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-11 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-12-11 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-12-11 | Citigroup | Buy | Buy | Maintains |
| 2024-11-19 | Erste Group | Hold | Buy | Upgrade |
| 2025-01-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-01-24 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2025-01-24 | Raymond James | Outperform | Outperform | Maintains |
| 2025-01-24 | Truist Securities | Buy | Buy | Maintains |
| 2025-01-24 | Citigroup | Buy | Buy | Maintains |
| 2025-01-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-03-18 | Baird | Outperform | Outperform | Maintains |
| 2025-03-17 | Truist Securities | Buy | Buy | Maintains |
| 2025-04-24 | Barclays | Overweight | Overweight | Maintains |
| 2025-05-22 | Citigroup | Buy | Buy | Maintains |
| 2025-06-09 | Deutsche Bank | Hold | Sell | Downgrade |
| 2025-08-19 | RBC Capital | Outperform | Outperform | Reiterate |
